Arbutus Biopharma (ABUS) Reports In-Line Q3 EPS; Cash and Cash Equivalents of 151.9M

Go back to Arbutus Biopharma (ABUS) Reports In-Line Q3 EPS; Cash and Cash Equivalents of 151.9M

Arbutus Biopharma (ABUS) Files $250M Mixed Shelf

November 4, 2021 5:12 PM EDT

Arbutus Biopharma (NASDAQ: ABUS) files $250,000,000 mixed shelf of:

Common Shares
Preferred Shares
Warrants
Debt Securities
Units

... More